Search research articles
Contact Us
Filters
Showing results (291-300 of 376) with videos related to
Page
of 38
Sort By:
Frontiers in Health Services
|
February 4, 2025
Economic evaluation of a strategy to shorten the time to surgery with neuraxial anaesthesia compared with usual clinical practice in patients on chronic antiplatelet therapy with a proximal femur fracture
Claudia Erika Delgado-Espinoza, Rosa Maria Antonijoan, Ignasi Gich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 28, 2012
Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland
Alicia Hernández-Vivanco, Alberto Pérez-Alvarez, José Carlos Caba-González, et al.
Transcultural Psychiatry
|
January 12, 2022
Perceived Discrimination, Experiential Avoidance, and Mental Health among Hispanic Adults in Primary Care
Michael J Zvolensky, Andrew H Rogers, Nubia A Mayorga, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 23, 2014
Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis
Fabian Sanchis-Gomar, Alejandro Lucia, Thomas Yvert, et al.
Investigational New Drugs
|
August 22, 2013
Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study
Normand Blais, D Ross Camidge, Derek J Jonker, et al.
Investigational New Drugs
|
January 18, 2012
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors
Toshiaki Takahashi, Narikazu Boku, Haruyasu Murakami, et al.
Cancer Chemotherapy and Pharmacology
|
October 31, 2012
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma
D Ross Camidge, Normand Blais, Derek J Jonker, et al.
Molecular Brain
|
March 2, 2016
Specific cytoarchitectureal changes in hippocampal subareas in daDREAM mice
Britt Mellström, Asta Kastanauskaite, Shira Knafo, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
February 4, 2016
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group
Peter L Bonate, Malidi Ahamadi, Nageshwar Budha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 7, 2018
Cardiorespiratory fitness and adiposity in breast cancer survivors: is meeting current physical activity recommendations really enough?
Alejandro Santos-Lozano, Javier Ramos, Alejandro Alvarez-Bustos, et al.
Page
of 38
Search research articles
Search
Showing results (291-300 of 376) with videos related to
Sort By:
Page
of 38
Frontiers in Health Services
|
February 4, 2025
Economic evaluation of a strategy to shorten the time to surgery with neuraxial anaesthesia compared with usual clinical practice in patients on chronic antiplatelet therapy with a proximal femur fracture
Claudia Erika Delgado-Espinoza, Rosa Maria Antonijoan, Ignasi Gich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 28, 2012
Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland
Alicia Hernández-Vivanco, Alberto Pérez-Alvarez, José Carlos Caba-González, et al.
Transcultural Psychiatry
|
January 12, 2022
Perceived Discrimination, Experiential Avoidance, and Mental Health among Hispanic Adults in Primary Care
Michael J Zvolensky, Andrew H Rogers, Nubia A Mayorga, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 23, 2014
Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis
Fabian Sanchis-Gomar, Alejandro Lucia, Thomas Yvert, et al.
Investigational New Drugs
|
August 22, 2013
Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study
Normand Blais, D Ross Camidge, Derek J Jonker, et al.
Investigational New Drugs
|
January 18, 2012
Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kinases, in Japanese patients with advanced solid tumors
Toshiaki Takahashi, Narikazu Boku, Haruyasu Murakami, et al.
Cancer Chemotherapy and Pharmacology
|
October 31, 2012
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma
D Ross Camidge, Normand Blais, Derek J Jonker, et al.
Molecular Brain
|
March 2, 2016
Specific cytoarchitectureal changes in hippocampal subareas in daDREAM mice
Britt Mellström, Asta Kastanauskaite, Shira Knafo, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
February 4, 2016
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group
Peter L Bonate, Malidi Ahamadi, Nageshwar Budha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 7, 2018
Cardiorespiratory fitness and adiposity in breast cancer survivors: is meeting current physical activity recommendations really enough?
Alejandro Santos-Lozano, Javier Ramos, Alejandro Alvarez-Bustos, et al.
Page
of 38